Ameridose Pulls Back All Products; Recall Tied to NECC

Ameridose is recalling all of its unexpired product as an ongoing FDA inspection of its Westborough, Mass., facility has raised sterility concerns. The company agreed to stop all pharmacy and manufacturing operations at the facility on Oct. 10 under an agreement with the Massachusetts Board of Registration in Pharmacy, the FDA said.
Drug Industry Daily